Measurement of Intracellular Oxygen Concentration During Photodynamic Therapy in vitro

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Photochemistry and Photobiology

• Publication date

  2014-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/php.12256PMID 24521344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements.

  2012cited by this paper
• Calculation of Singlet Oxygen Dose Using Explicit and Implicit Dose Metrics During Benzoporphyrin Derivative Monoacid Ring A (BPD‐MA)‐PDT In Vitro and Correlation with MLL Cell Survival

  2011cited by this paper
• Calculation of cellular oxygen concentration for photodynamic therapy in vitro.

  2010cited by this paper
• A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen

  2010cited by this paper
• Metronomic PDT and cell death pathways.

  2010cited by this paper
• Simple Photodynamic Therapy Dose Models Fail to Predict the Survival of MLL Cells After HPPH–PDT In Vitro

  2009cited by this paper
• Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes.

  2005cited by this paper
• Photophysical Parameters, Photosensitizer Retention and Tissue Optical Properties Completely Account for the Higher Photodynamic Efficacy of meso-Tetra-Hydroxyphenyl-Chlorin vs Photofrin¶

  2005cited by this paper
• Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro

  2005cited by this paper
• Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells ¶

  2005cited by this paper
• Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶

  2004cited by this paper
• Quantitative determination of localized tissue oxygen concentration in vivo by two-photon excitation phosphorescence lifetime measurements.

  2004cited by this paper
• Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms.

  2004cited by this paper
• Photodynamic therapy: Biophysical mechanisms and molecular responses

  2004influential reference
• In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy.

  2003cited by this paper
• Direct Near‐infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo ¶

  2002cited by this paper
• Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶

  2002cited by this paper
• Photodynamic Therapy of Human Glioma Spheroids Using 5-Aminolevulinic Acid¶

  2000cited by this paper
• Photochemical oxygen consumption sensitized by a porphyrin phosphorescent probe in two model systems.

  2000cited by this paper
• The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry

  1997cited by this paper
• Calibration of Pd-porphyrin phosphorescence for oxygen concentration measurements in vivo.

  1996cited by this paper
• Pericellular PO2 and O2 consumption in monolayer cell cultures.

  1995cited by this paper
• Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids.

  1994cited by this paper
• Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice.

  1994cited by this paper
• Microelectrode measurements of pericellular PO2 in erythropoietin-producing human hepatoma cell cultures.

  1993cited by this paper
• Oxygen distribution in the retinal and choroidal vessels of the cat as measured by a new phosphorescence imaging method.

  1992cited by this paper
• Oxygen gradients in CHO cells: Measurement and characterization by electron spin resonance

  1989cited by this paper
• An optical method for measurement of dioxygen concentration based upon quenching of phosphorescence.

  1987cited by this paper
• Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

  1976cited by this paper

• Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

  2025cites this paper
• Optical instrumentations monitoring dosimetric parameters for photodynamic therapy

  2025cites this paper
• Effect of intermittency factor on singlet oxygen and PGE2 formation in azulene-mediated photodynamic therapy: A preliminary study

  2022cites this paper
• Photobleaching characteristics of α-(8-quinolinoxy) zinc phthalocyanine, a new type of amphipathic complex

  2017cites this paper
• The First Decade ( 1964-1972 ) R search

  2017cites this paper
• Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.

  2017cites this paper
• New strategies to enhance photodynamic therapy for solid tumors

  2016cites this paper
• The biophysical aspects of photodynamic therapy

  2016cites this paper
• Photodynamic therapy with liposomal zinc phthalocyanine and tirapazamine increases tumor cell death via DNA damage

  2016cites this paper
• Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies

  2015cites this paper
• Validation and Application of a Model of Oxygen Consumption and Diffusion During Photodynamic Therapy In Vitro

  2014cites this paper